CSBR revenue rises 8.8% to $15.2 million
Revenue rose 8.8% year over year to $15.2 million. Oncology services margin improved to 51%, adjusted EBITDA was $671,000 and net loss narrowed to $426,000.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.